During the past decade, Okayama University Hospital conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 58 clinical trials were completed, i.e. on average, 35.4% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 42 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Okayama University Hospital" #1 sponsor was "Hoffmann-La Roche" with 20 trials, followed by "Pfizer" with 19 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored, "Takeda" with 10 trials sponsored and "Boehringer Ingelheim" with 10 trials sponsored. Other sponsors include 132 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Okayama University Hospital" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "Maruishi Pharmaceutical" with 3 trials as a collaborator and "Boehringer Ingelheim" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Okayama University Hospital" are "Non-Small Cell Lung Cancer" (9 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials), "Multiple Myeloma" (8 trials), "Ulcerative Colitis" (6 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Okayama University Hospital" in a lesser frequency.

Most popular intervention types in "Okayama University Hospital" are "Drug" (171 trials), "Biological" (10 trials), "Device" (10 trials), "Other" (10 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Atezolizumab" (10 trials), "Pemetrexed" (10 trials), "Cisplatin" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Okayama University Hospital" are 195 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Okayama University Hospital". undefined are not yet recruiting, 51 are recruiting, 60 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 76 completed trials in Okayama University Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Okayama University Hospital, 17 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".